Index of reports
> Death (2)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Vibativ (Telavancin) death. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Vibativ side effects in female
Reported by a pharmacist from United States on 2012-02-21
Patient: female
Reactions: Death, Hospitalisation, Multiple-Drug Resistance, Disease Progression
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Vibativ
Possible Vibativ side effects in male
Reported by a physician from United States on 2011-10-10
Patient: male
Reactions: Myocardial Infarction, Blood Creatinine Increased
Adverse event resulted in: death
Drug(s) suspected as cause:
Vibativ
Other drugs received by patient: Diuretic
|